Smartphone-based detection of subtle memory decline in prodromal Alzheimer’s disease - Scorecard - MDSpire

Smartphone-based detection of subtle memory decline in prodromal Alzheimer’s disease

  • By

  • Sarah E. Polk

  • Lindsay R. Clark

  • Kristin Basche

  • Luca Kleineidam

  • Wenzel Glanz

  • Michaela Butryn

  • Robert Perneczky

  • Katharina Buerger

  • Klaus Fliessbach

  • Christoph Laske

  • Annika Spottke

  • Anja Schneider

  • Jens Wiltfang

  • Stefan Teipel

  • Claudia Bartels

  • Ayda Rostamzadeh

  • Daniel Janowitz

  • Boris-Stephan Rauchmann

  • Ingo Kilimann

  • Sebastian Sodenkamp

  • Marie Coenjaerts

  • Frederic Brosseron

  • Michael Wagner

  • Ingo Frommann

  • Melina Stark

  • Matthias Schmid

  • Björn H. Schott

  • Sterling C. Johnson

  • Frank Jessen

  • Emrah Düzel

  • David Berron

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Digital Assessment via Smartphones Identifies Early Memory Impairment in Prodromal Alzheimer's Disease

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationIndividuals aged 52–85, cognitively unimpaired or diagnosed with mild cognitive impairment (MCI), with a clear distinction.
Care Setting

Key Highlights

  • highlight_3

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement frequent cognitive testing to monitor subtle cognitive decline, specifying recommended tests.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Detail how frequent digital assessments can lead to timely clinical management.

        Clinical Best Practices

        • practice_1

        Related Resources & Content

          Original Source(s)

          Smartphone-based detection of subtle memory decline in prodromal Alzheimer’s disease

          • by Sarah E. Polk, Lindsay R. Clark, Kristin Basche, Luca Kleineidam, Wenzel Glanz, Michaela Butryn, Robert Perneczky, Katharina Buerger, Klaus Fliessbach, Christoph Laske, Annika Spottke, Anja Schneider, Jens Wiltfang, Stefan Teipel, Claudia Bartels, Ayda Rostamzadeh, Daniel Janowitz, Boris-Stephan Rauchmann, Ingo Kilimann, Sebastian Sodenkamp, Marie Coenjaerts, Frederic Brosseron, Michael Wagner, Ingo Frommann, Melina Stark, Matthias Schmid, Björn H. Schott, Sterling C. Johnson, Frank Jessen, Emrah Düzel, David Berron

          • June 10, 2026

          Related Content

          Editorial: Cross-talk of synaptic proteins in neurological diseases

          The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease

          Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE)